1. Home
  2. GDL vs BTMD Comparison

GDL vs BTMD Comparison

Compare GDL & BTMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo GDL Fund The of Beneficial Interest

GDL

GDL Fund The of Beneficial Interest

SELL

Current Price

$8.49

Market Cap

90.7M

Sector

Finance

ML Signal

SELL

Logo Biote Corp.

BTMD

Biote Corp.

HOLD

Current Price

$1.94

Market Cap

72.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GDL
BTMD
Founded
2006
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Investment Managers
Medicinal Chemicals and Botanical Products
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
90.7M
72.7M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
GDL
BTMD
Price
$8.49
$1.94
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$2.83
AVG Volume (30 Days)
6.6K
183.7K
Earning Date
01-01-0001
05-06-2026
Dividend Yield
6.02%
N/A
EPS Growth
N/A
722.22
EPS
N/A
0.06
Revenue
N/A
$192,219,000.00
Revenue This Year
N/A
$2.03
Revenue Next Year
N/A
$6.58
P/E Ratio
N/A
$31.75
Revenue Growth
N/A
N/A
52 Week Low
$8.19
$1.27
52 Week High
$8.67
$4.75

Technical Indicators

Market Signals
Indicator
GDL
BTMD
Relative Strength Index (RSI) 54.91 42.47
Support Level $8.39 $1.35
Resistance Level $8.53 $2.79
Average True Range (ATR) 0.05 0.15
MACD -0.00 -0.05
Stochastic Oscillator 58.88 15.91

Price Performance

Historical Comparison
GDL
BTMD

About GDL GDL Fund The of Beneficial Interest

GDL Fund is a diversified closed-end management investment company. Its primary investment objective is to achieve absolute returns in various market conditions without excessive risk of capital. The fund seeks to achieve its objective by investing in merger arbitrage transactions and, to a lesser extent, in corporate reorganizations involving stubs, spin-offs, and liquidations.

About BTMD Biote Corp.

Biote Corp operates a growth practice-building business within the hormone optimization space. It provides the necessary components to enable Biote-certified practitioners to establish, build, and successfully implement a program designed to optimize hormone levels using personalized solutions for their patient populations. The company provides support to medical practitioners through training, practice development, and operational services to establish and manage hormone therapy centers. Its activities include educating practitioners on identifying and treating hormone-related conditions. The company generates revenues by charging the Biote-partnered clinics fees associated with the Biote Method and from the sale of Biote-branded dietary supplements.

Share on Social Networks: